Nika BioTechnology Inc
Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika P… Read more
Market Cap & Net Worth: Nika BioTechnology Inc (NIKA)
Nika BioTechnology Inc (PINK:NIKA) has a market capitalization of $1.04 Billion ($1.04 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #13403 globally and #5558 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nika BioTechnology Inc's stock price $1.00 by its total outstanding shares 1039836001 (1.04 Billion).
Nika BioTechnology Inc Market Cap History: 2015 to 2025
Nika BioTechnology Inc's market capitalization history from 2015 to 2025. Data shows growth from $160.65 Million to $1.04 Billion (21.81% CAGR).
Nika BioTechnology Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nika BioTechnology Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1830.35x
Nika BioTechnology Inc's market cap is 1830.35 times its annual revenue
1.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $155.98 Million | $85.22K | -$14.71K | 1830.35x | N/A |
Competitor Companies of NIKA by Market Capitalization
Companies near Nika BioTechnology Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Nika BioTechnology Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Nika BioTechnology Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Nika BioTechnology Inc's market cap moved from $160.65 Million to $ 1.04 Billion, with a yearly change of 21.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.04 Billion | +97.16% |
| 2024 | $527.40 Million | +54.30% |
| 2023 | $341.79 Million | -77.17% |
| 2022 | $1.50 Billion | +860.00% |
| 2021 | $155.98 Million | -55.56% |
| 2020 | $350.94 Million | +125.00% |
| 2019 | $155.98 Million | -66.78% |
| 2018 | $469.49 Million | +903.33% |
| 2017 | $46.79 Million | -70.00% |
| 2016 | $155.98 Million | -2.91% |
| 2015 | $160.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Nika BioTechnology Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.04 Billion USD |
| MoneyControl | $1.04 Billion USD |
| MarketWatch | $1.04 Billion USD |
| marketcap.company | $1.04 Billion USD |
| Reuters | $1.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.